Science
ADC-IO Combinations in Urothelial Cancer at the 2026 SITC EU Immuno-Oncology Drug Development Summit
Society for Immunotherapy of Cancer (SITC)/sitcancer.org

ADC-IO Combinations in Urothelial Cancer at the 2026 SITC EU Immuno-Oncology Drug Development Summit

Society for Immunotherapy of Cancer (SITC) shared on LinkedIn:

“See how ADC-IO combinations are reshaping urothelial cancer treatment at the 2026 SITC EU Immuno-Oncology Drug Development Summit.

Don’t miss this featured session.

Register today: 2026 SITC EU Immuno-Oncology Drug Development Summit.”

SITC

Other articles about Immuno-Oncology and urothelial cancer on OncoDaily.

cancer CIMT immuno-oncology OncoDaily Oncology Oslo Cancer Cluster SITC Society for Immunotherapy of Cancer Swiss Biotech Association urothelial cancer